Company Quick10K Filing
Emmaus Life Sciences
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-21
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-19
10-Q 2016-03-31 Filed 2016-06-06
10-K 2015-12-31 Filed 2016-05-20
10-K 2015-09-30 Filed 2016-05-20
10-Q 2015-06-30 Filed 2016-05-20
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-05-08
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-29
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-04-30 Filed 2011-05-13
10-Q 2011-01-31 Filed 2011-03-11
10-K 2010-10-31 Filed 2011-01-31
10-Q 2010-07-31 Filed 2010-09-14
10-Q 2010-04-30 Filed 2010-06-14
10-Q 2010-01-31 Filed 2010-03-17
10-K 2009-10-31 Filed 2010-01-29
8-K 2019-07-09 Other Events, Exhibits
8-K 2019-07-08 Other Events, Exhibits
8-K 2019-07-03 Other Events, Exhibits
8-K 2019-06-12 Other Events, Exhibits
8-K 2019-05-29 Officers, Other Events, Exhibits
8-K 2019-03-05 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2019-01-04 Enter Agreement, Regulation FD, Exhibits
8-K 2018-12-19 Amend Bylaw, Exhibits
8-K 2018-10-09 Enter Agreement
8-K 2018-09-27 Officers, Shareholder Vote
8-K 2018-09-13 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-07-16 Officers
8-K 2018-06-13 Officers
8-K 2018-03-29 Enter Agreement, Exhibits
8-K 2018-01-30 Enter Agreement
8-K 2017-12-29 Leave Agreement, Exhibits

Emmaus Life Sciences Financials

EMMA Metrics, Comps, Filings

Quarterly | Annual

Business

In this discussion, the terms, "we," "us," "our" or the "Company" refer to Emmaus Life Sciences, Inc., and its direct and indirect wholly‑owned subsidiaries.

On January 7, 2019, we announced our entry into an Agreement and Plan of Merger and Reorganization, dated as of January 4, 2019 (as it may be amended, the "MYnd Merger Agreement"), among Emmaus, MYnd Analytics, Inc. ("Parent" or "MYnd") and Athena Merger Subsidiary, Inc. ("Merger Sub"), pursuant to which Merger Sub will merge (the "Merger") with and into Emmaus, with Emmaus surviving as a subsidiary of Parent. For a discussion of risks and uncertainties relating to the Merger, see "Risk Factors - Risks Relating to the Proposed Merger" in this Annual Report.

We are a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, primarily for rare and orphan diseases and a leader in the treatment of sickle cell disease, or SCD. On July 7, 2017, the U.S. Food and Drug Administration, or FDA, approved our lead product, Endari™ (L-glutamine oral powder), to reduce the acute complications of SCD in adult and pediatric patients five years of age and older.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
First Northern Community Bancorp (FNRN) 136,114 0.0 1% 1,287,263 1,157,741 0 0 11,145 16,699 21
JRSIS Health Care (JRSS) 135,419 0% 23.1 5% 53,817 29,543 22,907 0 2,913 5,783 133,410
magicJack VocalTec (CALL) 135,362 64% 5.6 5% 144,276 95,065 80,267 51,525 6,495 13,150 73,254
Federal Street Acquisition (FSAC) 135,270 -26.8 -1% 471,272 25,787 0 0 -3,966 -4,930 132,081
Invesco DB Precious Metals Fund (DBP) 133,440 10.1 10% 133,936 3,438 0 0 13,252 13,252 133,440
Bright Mountain Media (BMTM) 132,589 27% -40.9 -12% 28,364 7,229 3,915 1,041 -3,451 -3,224 132,001
Living 3D (LTDH) 131,496 -27% -587.9 -294% 80 957 36 -10 -236 -224 131,491
Darkpulse (KLMK) 130,846 -596.4 -114% 576 3,218 0 0 -659 -221 131,978
Invesco CurrencyShares Canadian Dollar Trust (FXC) 129,195 0% -23.9 1% 115,580 40 1,541 0 993 993 -23,705
Gastar Exploration (GST) 129,171 0% -45.1 -24% 335,253 447,533 82,913 0 -81,839 -10,744 484,737
Contango Ore (CTGO) 128,732 -16.5 -96% 7,639 407 0 0 -7,322 -7,322 121,121
Emmaus Life Sciences (EMMA) 128,334 96% -5.7 -66% 70,735 95,363 12,760 12,198 -46,927 -28,944 165,192
RenovaCare (RCAR) 126,661 -51.9 -16% 13,627 483 0 0 -2,183 -2,183 113,287
WMIH (WMIH) 126,089 0% -1.9 -2% 18,478,000 16,711,000 1,519,000 0 -325,000 267,000 -515,911
Coastway Bancorp (CWAY) 122,160 6.2 0% 834,904 761,474 0 0 3,067 11,692 72,076
SteadyMed (STDY) 121,680 0% -6.0 -61% 27,830 23,512 430 0 -16,924 -16,656 100,551
Amplify Energy (AMPY) 121,564 0% 2.7 9% 722,684 317,597 285,911 0 63,813 101,197 277,537
Axcella Health (AXLA) 121,267 -1.0 -40% 109,187 34,843 0 0 -43,324 -42,806 41,912
Mobiquity Technologies (MOBQ) 121,110 42% -3.5 -192% 18,378 5,177 6,647 2,816 -35,292 -34,760 120,580
ENB Financial (ENBP) 120,929 9.2 1% 1,145,998 1,030,361 0 0 10,841 17,453 159,728

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash4326033141623983344031375435,7733,6391,5353,6051,6415563281,5814834723243236,6281,3173,5455,0884,41522,5565,1132,16916,66217,08015,310
Accounts Receivable39781876435280444525352765544315212310261542014271110276851,7021,4151,3511,760
Inventory2822341952152402562031651621682392532592242502682232952193022422521662612713966251,0082,4353,3474,7055,795
PP&E83786055192195196196197201204225227229265267267270270271274275281326359361361376414441454456
Assets3,6773,2162,4824,1723,3153,0842,8843,0933,7939,0346,1143,6165,8203,6582,6642,2073,4472,2841,4771,3451,26321,56212,99315,38648,42433,604123,845113,50273,93584,80674,55570,735
Accounts Payable1,3511,6581,7581,9671,4931,3248369145946551,2181,7524541,1871,5241,4701,7451,3394769528881,2721,6001,7902,9862,6463,6045,186
Long-Term Debt8,1479,43211,30512,41411,49311,49911,46711,55513,13711,72311,98613,07917,42017,71519,12818,89920,68018,07316,69618,88019,94924,30948,72440,40240,31949,99355,17252,168
Liabilities3,7124,6375,4578,43110,71512,44413,52715,34113,87716,30519,95122,86325,25823,61622,96424,32325,99427,31330,04031,69632,93730,84630,55436,96776,17189,490109,555101,986103,22396,35190,44995,363
Stockholders' Equity-35-1,422-2,975-4,260-7,400-9,360-10,643-12,248-10,084-7,271-13,838-19,247-19,438-19,958-20,300-22,116-22,547-25,030-28,563-30,351-31,674-9,284-17,562-21,581-27,748-55,88514,29111,516-29,289-11,545-15,797-24,546
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue981522814510711317890916614485126156153971447727279173621481071641401477812,5714,8825,307
Cost of Revenue4657421293797446248494761906950643713628832189487312962135221141200
Gross Profit5295241251087780463618953867658447814013651904159599212856472,3504,7415,107
R&D3385333715438967807576156964906356057115072572443034655675025853695327561,584379483411396466513
SG&A1,6532,2191,0231,6352,6711,8782,5262,5343,3992,7212,5983,1123,7812,8743,1973,3722,4472,2522,3872,3412,7602,2942,9013,7473,4386,3624,6774,7116,4065,166
Tax0036001320-1852201220200120010
Net Income-1,947-2,913-2,841-2,945-4,195-3,452-3,842-3,363-3,662-3,708-3,245-6,740-7,378-3,726-2,972-3,604-1,655-3,444-4,460-3,142-6,258-7,318-6,495-11,776-17,2672,166-6,097-47,34314,569-14,153
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-2,450-1,505-1,014-1,794-1,613-2,028-1,436-2,339-1,937-2,677-2,172-2,876-2,218-1,469-1,228-1,235-1,486-2,360-2,071-15,4159,8131,966579-5,91327,563-615-1,665-1,284
Cash Investing-11-1,502-3-200-1-4588-21-2-2-38-10-14,008-40-44-2-31,974-4846,380-16
Cash Financing2,6221,2182,3672,0681,5532,0691,1762,7707,178-65884,9482604251,0021261,4312,2082,06721,650-1,0312999685,23422,616-16,3309,775-492